Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Clinical trial NCT00457015 · COMPLETED

Trial details

NCT number: NCT00457015
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)

Start date: 2007-04-01
Primary completion: 2008-06-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.